C4 Therapeutics, Inc.
NASDAQC4 Therapeutics heads into the week of May 11 with a striking divergence: short sellers are heavily dug in at more than a quarter of the free float, yet options traders are leaning bullish at a pace not seen in months. The short position is the dominant feature of this setup. At roughly 26% of the free float — cross-confirmed by FINRA's April 30 fortnightly report at approximately…
Snapshot as of 28 Jun 2026
C4 Therapeutics heads into the week of May 11 with a striking divergence: short sellers are heavily dug in at more than a quarter of the free float, yet options traders are leaning bullish at a pace not seen in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CCCC — free to start on ORTEX.
Sign up for free →Open CCCC on ORTEX